<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SSC</journal-id><journal-title-group><journal-title>Studies in Synthetic Chemistry</journal-title></journal-title-group><issn pub-type="epub">2332-7944</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/SSC.2019.72002</article-id><article-id pub-id-type="publisher-id">SSC-30643</article-id><article-categories><subj-group subj-group-type="heading"><subject>SSC20190200000_28508769.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  1-苄基哌啶衍生物的合成研究
  The Synthesis of 1-Benzylpiperidine Derivatives
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>君</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>陈</surname><given-names>子仁</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>晨江</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>新疆大学化学化工学院，石油天然气精细化工教育部&amp;amp;自治区重点实验室，新疆 乌鲁木齐</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>06</month><year>2019</year></pub-date><volume>07</volume><issue>02</issue><fpage>7</fpage><lpage>10</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  以1-苄基哌啶酮为原料，先与苯胺和三甲基硅氰发生Strecker反应得到化合物2，再经过酰胺化、甲酯化、N-丙酰化等三步反应，以26%的总收率合成了1-苄基哌啶酮衍生物，产物结构经1H NMR、13C NMR和HRMS表征。该方法具有绿色、简便的特点。
   The compound 2 was prepared by the Strecker reaction of 1-benzylpiperidone with aniline and trimethylsilyl cyanide. Then 1-benzylpiperidone derivatives were synthesized in 26% overall yield by amidation, methyl esterification and N-propionylation. The structure of the product was characterized by 1H NMR, 13C NMR and HRMS. The method is green and simple.
 
</p></abstract><kwd-group><kwd>1-苄基哌啶，衍生物，合成，表征, 1-Benzylpiperidine</kwd><kwd> Derivative</kwd><kwd> Synthesis</kwd><kwd> Characterization</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1-苄基哌啶衍生物的合成研究<sup> </sup></title><p>王君，陈子仁，刘晨江<sup>*</sup></p><p>新疆大学化学化工学院，石油天然气精细化工教育部&amp;自治区重点实验室，新疆 乌鲁木齐</p><p><img src="//html.hanspub.org/file/1-3160068x1_hanspub.png" /></p><p>收稿日期：2019年5月17日；录用日期：2019年5月29日；发布日期：2019年6月5日</p><disp-formula id="hanspub.30643-formula15"><graphic xlink:href="//html.hanspub.org/file/1-3160068x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>以1-苄基哌啶酮为原料，先与苯胺和三甲基硅氰发生Strecker反应得到化合物2，再经过酰胺化、甲酯化、N-丙酰化等三步反应，以26%的总收率合成了1-苄基哌啶酮衍生物，产物结构经<sup>1</sup>H NMR、<sup>13</sup>C NMR和HRMS表征。该方法具有绿色、简便的特点。</p><p>关键词 :1-苄基哌啶，衍生物，合成，表征</p><disp-formula id="hanspub.30643-formula16"><graphic xlink:href="//html.hanspub.org/file/1-3160068x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/1-3160068x8_hanspub.png" /> <img src="//html.hanspub.org/file/1-3160068x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>1962年，Janssen等人 [<xref ref-type="bibr" rid="hanspub.30643-ref1">1</xref>] 首次报道一种镇痛药——芬太尼，该药物在临床中被广泛用于中、重度癌症治疗的镇痛和麻醉药物 [<xref ref-type="bibr" rid="hanspub.30643-ref2">2</xref>] ，具有起效快、作用强、代谢不依赖肝肾功能等优点 [<xref ref-type="bibr" rid="hanspub.30643-ref3">3</xref>] 。因此，该类化合物的研究受到人们的关注 [<xref ref-type="bibr" rid="hanspub.30643-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref7">7</xref>] 。1-苄基哌啶衍生物是芬太尼类化合物的基本骨架，因此探索1-苄基哌啶衍生物的合成方法至关重要。本文在前人研究的基础上，以1-苄基哌啶酮(化合物1)为原料，先与苯胺和三甲基硅氰在甲醇和水的混合溶剂中反应，再在碳酸钾存在的条件下与双氧水作用发生酰胺化反应，继而以对甲苯磺酸为酸性催化剂与甲醇反应，最后和丙酰氯作用制备了1-苄基哌啶衍生物(合成路线见图1)，产物总收率26%，其结构经<sup>1</sup>H NMR、<sup>13</sup>C NMR和HRMS确证。</p><p>图1. 1-苄基哌啶衍生物的合成</p></sec><sec id="s4"><title>2. 实验部分</title><sec id="s4_1"><title>2.1. 仪器与试剂</title><p>Varian inova-400型核磁共振仪(美国瓦里安有限公司)；美国Thermo Q-Exactive高分辨质谱仪(美国Waters公司)；瑞士B&#252;chi B-560型熔点仪(瑞士B&#252;chi公司)等。</p><p>所用药品和试剂均为市售分析纯；溶剂在使用前进行重新蒸馏处理。</p></sec><sec id="s4_2"><title>2.2. 1-苄基哌啶衍生物的合成</title><sec id="s4_2_1"><title>2.2.1. 1-苄基-4-氰基-4-苯氨基哌啶(化合物2)的合成</title><p>在冰浴、搅拌的条件下将58.8 mmol苯胺加入到溶有53.9 mmol 1-苄基哌啶酮的10.0 mL甲醇溶液中，继而将溶有58.0 mmol三甲基硅氰的26.0 mL蒸馏水和甲醇混合溶剂(V<sub>蒸馏水</sub>:V<sub>蒸馏水</sub> = 1:1)缓慢滴加到上述溶液中，然后缓慢滴加5.4 mL冰醋酸。撤去冰浴，反应液在30℃反应24 h，抽滤，依次用甲醇和蒸馏水洗涤滤饼，真空干燥24 h，以75%产率得到化合物2，白色粉末状固体。</p><p>化合物2结构表征如下：</p><p>化合物2 [<xref ref-type="bibr" rid="hanspub.30643-ref8">8</xref>] : white solid, m.p. 145℃~146℃, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35-7.29 (m, 4H), 7.29-7.21 (m, 3H), 6.96-6.86 (m, 3H), 3.64 (s, 1H), 3.57 (s, 2H), 2.82 (d, J = 11.6 Hz, 2H), 2.48 (t, J = 10.8 Hz, 2H), 2.33 (d, J = 13.6 Hz, 2H), 1.94 (t, J = 11.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 143.43, 129.44, 129.18, 128.52, 127.47, 121.12, 120.80, 118.00, 62.71, 53.25, 49.43, 36.21.HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>N<sub>3 </sub>([M+H]<sup>+</sup>): 292.18082, found 292.18039.</p></sec><sec id="s4_2_2"><title>2.2.2. 1-苄基-4-氨甲酰基-4-苯氨基哌啶(化合物3)的合成</title><p>将6.2 mmol K<sub>2</sub>CO<sub>3</sub>加入到溶有41.2 mmol化合物2的72 mL二甲亚砜溶液中，再将10.1 mLH<sub>2</sub>O<sub>2</sub> (30 wt%水溶液)缓慢滴加到上述溶液中，室温条件下反应24 h，倒入蒸馏水中，抽滤，用蒸馏水洗涤滤饼，除去残留二甲亚砜，真空干燥24 h，以90%产率得到化合物3，白色粉末状固体。</p><p>化合物3结构表征如下：</p><p>化合物3 [<xref ref-type="bibr" rid="hanspub.30643-ref9">9</xref>] : white solid, m.p. 192℃~193℃, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33-7.26 (m, 4H), 7.26-7.21 (m, 1H), 7.21-7.15 (m, 2H), 6.88 (s, 1H), 6.80 (t, J = 7.4 Hz, 1H), 6.67-6.59 (m, 2H), 5.48 (s, 1H), 4.03 (s, 1H), 3.50 (s, 2H), 2.75 (d, J = 12.4 Hz, 2H), 2.42-2.24 (m, 2H), 2.12 (t, J = 12.0 Hz, 2H), 1.93 (d, J = 12.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.62, 143.81, 129.31, 129.10, 128.38, 127.23, 119.37, 116.28, 63.08, 58.35, 48.87, 31.47.HRMS (ESI) calcd for C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>O ([M+H]<sup>+</sup>): 310.19139 found 310.19095.</p></sec><sec id="s4_2_3"><title>2.2.3. 1-苄基-4-甲氧羰基-4-苯氨基哌啶(化合物4)的合成</title><p>将8.1 mmol化合物3、29.0 mmol对甲苯磺酸和22.5 mL甲醇加入高压反应瓶中，105℃下反应36 h。冷却，减压旋除甲醇，滴加氨水将pH调至7~8，用二氯甲烷(3 &#215; 50 mL)萃取，合并有机相，无水硫酸钠干燥，抽滤除去干燥剂，将所得滤液减压旋除得残余物，经柱层析分离(V<sub>石油醚</sub>:V<sub>乙酸乙酯</sub> = 4 : 1 )，以50%产率得到化合物4，棕色油状液体。</p><p>化合物4结构表征如下：</p><p>化合物4 [<xref ref-type="bibr" rid="hanspub.30643-ref10">10</xref>] : brown oily liquid, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37-7.18 (m, 5H), 7.18-7.05 (m, 2H), 6.73 (t, J = 7.4 Hz, 1H), 6.55 (d, J = 7.6 Hz, 2H), 3.86 (s, 1H), 3.65 (s, 3H), 3.49 (s, 2H), 2.68-2.50 (m, 2H), 2.40 (t, J = 9.8 Hz, 2H), 2.30-2.15 (m, 2H), 2.08-1.95 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.96, 145.02, 138.40, 129.12, 128.29, 127.10, 118.63, 115.35, 63.02, 58.31, 52.32, 48.96, 33.05.HRMS (ESI) calcd forC<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2 </sub>([M+H]<sup>+</sup>): 325.19105 found 325.19070.</p></sec><sec id="s4_2_4"><title>2.2.4. 1-苄基-4-甲氧羰基-4-丙酰苯氨基哌啶(化合物5)的合成</title><p>在冰浴、搅拌的条件下，将15.4 mmol丙酰氯缓慢滴加到溶有7.7 mmol化合物4的10 mL无水二氯甲烷溶液中，加毕，撤去冰浴，40℃回流8 h。冷却，滴加氨水将pH调至7~8，用二氯甲烷(3 &#215; 30 mL)萃取，合并有机相，无水硫酸钠干燥，抽滤除去干燥剂，将所得滤液减压旋除得残余物，经柱层析分离(V<sub>石油醚</sub>:V<sub>乙酸乙酯</sub> = 4:1)，以78%产率得到化合物5，黄色油状液体。</p><p>化合物5结构表征如下：</p><p>化合物5 [<xref ref-type="bibr" rid="hanspub.30643-ref8">8</xref>] : yellow oily liquid,<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41 (d, J = 7.2 Hz, 3H), 7.34-7.28 (m, 3H), 7.24 (d, J = 8.6 Hz, 4H), 3.79 (s, 3H), 3.45 (s, 2H), 2.60 (d, J = 12.0 Hz, 2H), 2.49-2.33 (m, 2H), 2.27 (d, J = 13.2 Hz, 2H), 1.87 (q, J = 7.4 Hz, 2H), 1.71-1.56 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 174.08, 173.88, 139.28, 138.14, 130.49, 129.11, 128.87, 128.45, 128.03, 127.96, 126.76, 125.12, 62.74, 62.62, 51.82, 49.58, 33.34, 28.84, 8.94.HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3 </sub>([M+H]<sup>+</sup>): 381.21727 found 381.21658.</p></sec></sec></sec><sec id="s5"><title>3. 结果与讨论</title><p>前人报道的化合物2的合成方法 [<xref ref-type="bibr" rid="hanspub.30643-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref10">10</xref>] 大多都用剧毒物质KCN和NaCN作为氰基化试剂，本文采用相对绿色的有机氰化试剂TMSCN，并用甲醇和水的混合溶剂代替了冰醋酸，使得反应过程相对温和，同时产物以沉淀形式生成，易于后处理。我们参考文献 [<xref ref-type="bibr" rid="hanspub.30643-ref9">9</xref>] 合成了化合物3，即采用K<sub>2</sub>CO<sub>3</sub>为碱性添加剂、H<sub>2</sub>O<sub>2</sub>为氧化剂和DMSO为溶剂的水解体系代替浓硫酸的水解体系 [<xref ref-type="bibr" rid="hanspub.30643-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref10">10</xref>] ，实现了氰基水解成酰胺的高效转化，具有操作容易、后处理简单和产率高的优点。化合物4的N-丙酰化过程中，文献 [<xref ref-type="bibr" rid="hanspub.30643-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.30643-ref10">10</xref>] 报道的方法需要加入有机碱，本文将化合物4和丙酰氯在无碱的条件下反应，较好地避免了化合物4的分解，以78%的产率合成了N-丙酰化产物。</p></sec><sec id="s6"><title>4. 结论</title><p>1-苄基哌啶酮为原料，经过Strecker反应、酰胺化、甲酯化、N-丙酰化等步骤得到了1-苄基哌啶衍生物，总收率26%。该方法具有绿色、简便的特点。</p></sec><sec id="s7"><title>基金项目</title><p>乌鲁木齐市科学技术计划(NO.G151310001)。</p></sec><sec id="s8"><title>文章引用</title><p>王 君,陈子仁,刘晨江. 1-苄基哌啶衍生物的合成研究The Synthesis of 1-Benzylpiperidine Derivatives[J]. 合成化学研究, 2019, 07(02): 7-10. https://doi.org/10.12677/SSC.2019.72002</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.30643-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Janssen, P.A. (1962) A Review of the Chemical Features Associated with Strong Morphine-Like Activity. British Journal of Anaes-thesia, 34, 260-268. &lt;br&gt;https://doi.org/10.1093/bja/34.4.260</mixed-citation></ref><ref id="hanspub.30643-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">夏晴, 夏静. 2010-2012年我院麻醉药品应用情况分析[J]. 西北药学杂志, 2014, 29(5): 534-537.</mixed-citation></ref><ref id="hanspub.30643-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">杨森, 许青. 芬太尼及其衍生物治疗癌性疼痛的研究进展[J]. 上海医药, 2015, 36(5): 32-36.</mixed-citation></ref><ref id="hanspub.30643-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">周博宇, 胡文祥. 芬太尼类似物结构修饰中高活性基团研究[J]. 中国医药指南, 2010, 8(3): 27-31.</mixed-citation></ref><ref id="hanspub.30643-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Lian, M., Beckmen, K.B., Bentzen, T.W., Demma, D.J. and Arnemo, J.M. (2016) Thiafentanil-Azaperone-Xylazine and Carfentanil-Xylazine Immobilizations of Free-Ranging Caribou (Rangifer Tarandus Granti) in Alaska, USA. Journal of Wildlife Diseases, 52, 327-334.</mixed-citation></ref><ref id="hanspub.30643-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Riches, J.R., Read, R.W., Black, R.M., Cooper, N.J. and Timperley, C.M. (2012) Analysis of Clothing and Urine from Moscow Theatre Siege Casualties Reveals Carfentanil and Remifentanil Use. Journal of Analytical Toxicology, 36, 647-656. &lt;br&gt;https://doi.org/10.1093/jat/bks078</mixed-citation></ref><ref id="hanspub.30643-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">齐志敏, 谢艳蓉, 万宁, 张邦乐. 卡芬太尼的合成方法研究进展[J]. 西北药学杂志, 2017, 32(2): 238-241.</mixed-citation></ref><ref id="hanspub.30643-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">吴强三. 1-苄基-4-甲氧羰基芬太尼类化合物的合成及其比较分子场分析[D]: [硕士学位论文]. 北京: 首都师范大学, 2008.</mixed-citation></ref><ref id="hanspub.30643-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Srimurugan, S., Murugan, K. and Chen, C. (2009) A Facile Method for Preparation of [2H3]-Sufentanil and Its Metabolites. Chemical and Pharmaceutical Bulletin, 57, 1421-1424.</mixed-citation></ref><ref id="hanspub.30643-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Highet, R.J. and Jones, T.H. (1992) The Tautomer-ism of APhosphono Enamine. The Journal of Organic Chemistry, 57, 4038-4040. &lt;br&gt;https://doi.org/10.1021/jo00040a062</mixed-citation></ref></ref-list></back></article>